answer
stringlengths
1
16.1k
id
stringlengths
3
52
instruction
stringlengths
106
72.6k
ner_tags
sequence
text
stringlengths
5
72.4k
tokens
sequence
types
sequence
Synostose, fetalen Alkoholsyndroms, Arms, Differentialdiagnostik, Therapiemoeglichkeiten
DerUnfallchirurg.71000678.ger.abstr_2
Sentence: Ueber den seltenen Fall einer proximalen radioulnaren Synostose im Rahmen des fetalen Alkoholsyndroms eines 5 jaehrigen Maedchens wird berichtet . Trotz einer fixierten 30 Grad Pronationsstellung hatte die Patientin eine subjektiv nur minimal eingeschraenkte Funktion des rechten Arms . Wir diskutieren anhand des Fallbeispiels die Schwierigkeit der Differentialdiagnostik und die Therapiemoeglichkeiten fuer diese Art der Erkrankung des Bewegungsapparats . Instructions: please extract entity words from the input sentence
[ "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "B-umlsterm", "I-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O" ]
Ueber den seltenen Fall einer proximalen radioulnaren Synostose im Rahmen des fetalen Alkoholsyndroms eines 5 jaehrigen Maedchens wird berichtet . Trotz einer fixierten 30 Grad Pronationsstellung hatte die Patientin eine subjektiv nur minimal eingeschraenkte Funktion des rechten Arms . Wir diskutieren anhand des Fallbeispiels die Schwierigkeit der Differentialdiagnostik und die Therapiemoeglichkeiten fuer diese Art der Erkrankung des Bewegungsapparats .
[ "Ueber", "den", "seltenen", "Fall", "einer", "proximalen", "radioulnaren", "Synostose", "im", "Rahmen", "des", "fetalen", "Alkoholsyndroms", "eines", "5", "jaehrigen", "Maedchens", "wird", "berichtet", ".", "Trotz", "einer", "fixierten", "30", "Grad", "Pronationsstellung", "hatte", "die", "Patientin", "eine", "subjektiv", "nur", "minimal", "eingeschraenkte", "Funktion", "des", "rechten", "Arms", ".", "Wir", "diskutieren", "anhand", "des", "Fallbeispiels", "die", "Schwierigkeit", "der", "Differentialdiagnostik", "und", "die", "Therapiemoeglichkeiten", "fuer", "diese", "Art", "der", "Erkrankung", "des", "Bewegungsapparats", "." ]
[ "umlsterm" ]
tumor necrosis factor - alpha is a Protein, tissue factor is a Protein, CD36 is a Protein, endothelial selectins is a Protein, TNF - alpha is a Protein, TNF - alpha is a Protein, interleukin-1 beta is a Protein, IL-1 beta is a Protein, beta - actin is a Protein, cytokine genes is a Entity, CAT is a Protein, IL-1 beta is a Protein, promoter / enhancer sequences is a Entity, CAT is a Protein, IL-1 beta is a Protein, transcriptional factor activator protein-1 is a Entity, nuclear factor - kappa B is a Entity, SV40 promoter specific protein-1 is a Protein
394_0
Sentence: Engagement of the Lewis X antigen (CD15) results in monocyte activation. We previously reported that monocyte adhesion to tumor necrosis factor-alpha (TNF-alpha)-treated endothelial cells increased expression of tissue factor and CD36 on monocytes. Using immunological cross-linking to mimic receptor engagement by natural ligands, we now show that CD15 (Lewis X), a monocyte counter-receptor for endothelial selectins may participate in this response. We used cytokine production as a readout for monocyte activation and found that CD15 cross-linking induced TNF-alpha release from peripheral blood monocytes and cells from the monocytic cell line MM6. Quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) showed an increase in steady-state TNF-alpha mRNA after 3 to 4 hours of cross-linking. CD15 cross-linking also concomitantly increased interleukin-1 beta (IL-1 beta) mRNA, while no apparent change was observed in the levels of beta-actin mRNA, indicating specificity. To examine transcriptional regulation of cytokine genes by CD15 engagement, a CAT plasmid reporter construct containing IL-1 beta promoter/enhancer sequences was introduced into MM6. Subsequent cross-linking of CD15 increased CAT activity. CD15 engagement by monoclonal antibody also attenuated IL-1 beta transcript degradation, demonstrating that signaling via CD15 also had posttranscriptional effects. Nuclear extracts of anti-CD15 cross-linked cells demonstrated enhanced levels of the transcriptional factor activator protein-1, minimally changed nuclear factor-kappa B, and did not affect SV40 promoter specific protein-1. We conclude that engagement of CD15 on monocytes results in monocyte activation. In addition to its well-recognized adhesive role, CD15 may function as an important signaling molecule capable of initiating proinflammatory events in monocytes that come into contact with activated endothelium. Instructions: please extract entities and their types from the input sentence, all entity types are in options Options: Entity, Protein
[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "I-Protein", "I-Protein", "I-Protein", "I-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "I-Protein", "O", "B-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "I-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "I-Protein", "I-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "I-Protein", "I-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "I-Protein", "O", "B-Protein", "I-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "I-Protein", "I-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Entity", "I-Entity", "O", "O", "O", "O", "O", "B-Protein", "O", "O", "O", "O", "B-Protein", "I-Protein", "B-Entity", "I-Entity", "I-Entity", "I-Entity", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "I-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Entity", "I-Entity", "I-Entity", "I-Entity", "O", "O", "O", "B-Entity", "I-Entity", "I-Entity", "I-Entity", "I-Entity", "O", "O", "O", "O", "O", "B-Protein", "I-Protein", "I-Protein", "I-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ]
Engagement of the Lewis X antigen (CD15) results in monocyte activation. We previously reported that monocyte adhesion to tumor necrosis factor-alpha (TNF-alpha)-treated endothelial cells increased expression of tissue factor and CD36 on monocytes. Using immunological cross-linking to mimic receptor engagement by natural ligands, we now show that CD15 (Lewis X), a monocyte counter-receptor for endothelial selectins may participate in this response. We used cytokine production as a readout for monocyte activation and found that CD15 cross-linking induced TNF-alpha release from peripheral blood monocytes and cells from the monocytic cell line MM6. Quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) showed an increase in steady-state TNF-alpha mRNA after 3 to 4 hours of cross-linking. CD15 cross-linking also concomitantly increased interleukin-1 beta (IL-1 beta) mRNA, while no apparent change was observed in the levels of beta-actin mRNA, indicating specificity. To examine transcriptional regulation of cytokine genes by CD15 engagement, a CAT plasmid reporter construct containing IL-1 beta promoter/enhancer sequences was introduced into MM6. Subsequent cross-linking of CD15 increased CAT activity. CD15 engagement by monoclonal antibody also attenuated IL-1 beta transcript degradation, demonstrating that signaling via CD15 also had posttranscriptional effects. Nuclear extracts of anti-CD15 cross-linked cells demonstrated enhanced levels of the transcriptional factor activator protein-1, minimally changed nuclear factor-kappa B, and did not affect SV40 promoter specific protein-1. We conclude that engagement of CD15 on monocytes results in monocyte activation. In addition to its well-recognized adhesive role, CD15 may function as an important signaling molecule capable of initiating proinflammatory events in monocytes that come into contact with activated endothelium.
[ "Engagement", "of", "the", "Lewis", "X", "antigen", "(", "CD15", ")", "results", "in", "monocyte", "activation", ".", "\n", "We", "previously", "reported", "that", "monocyte", "adhesion", "to", "tumor", "necrosis", "factor", "-", "alpha", "(", "TNF", "-", "alpha)-treated", "endothelial", "cells", "increased", "expression", "of", "tissue", "factor", "and", "CD36", "on", "monocytes", ".", "Using", "immunological", "cross", "-", "linking", "to", "mimic", "receptor", "engagement", "by", "natural", "ligands", ",", "we", "now", "show", "that", "CD15", "(", "Lewis", "X", ")", ",", "a", "monocyte", "counter", "-", "receptor", "for", "endothelial", "selectins", "may", "participate", "in", "this", "response", ".", "We", "used", "cytokine", "production", "as", "a", "readout", "for", "monocyte", "activation", "and", "found", "that", "CD15", "cross", "-", "linking", "induced", "TNF", "-", "alpha", "release", "from", "peripheral", "blood", "monocytes", "and", "cells", "from", "the", "monocytic", "cell", "line", "MM6", ".", "Quantitative", "reverse", "transcriptase", "-", "polymerase", "chain", "reaction", "(", "RT", "-", "PCR", ")", "showed", "an", "increase", "in", "steady", "-", "state", "TNF", "-", "alpha", "mRNA", "after", "3", "to", "4", "hours", "of", "cross", "-", "linking", ".", "CD15", "cross", "-", "linking", "also", "concomitantly", "increased", "interleukin-1", "beta", "(", "IL-1", "beta", ")", "mRNA", ",", "while", "no", "apparent", "change", "was", "observed", "in", "the", "levels", "of", "beta", "-", "actin", "mRNA", ",", "indicating", "specificity", ".", "To", "examine", "transcriptional", "regulation", "of", "cytokine", "genes", "by", "CD15", "engagement", ",", "a", "CAT", "plasmid", "reporter", "construct", "containing", "IL-1", "beta", "promoter", "/", "enhancer", "sequences", "was", "introduced", "into", "MM6", ".", "Subsequent", "cross", "-", "linking", "of", "CD15", "increased", "CAT", "activity", ".", "CD15", "engagement", "by", "monoclonal", "antibody", "also", "attenuated", "IL-1", "beta", "transcript", "degradation", ",", "demonstrating", "that", "signaling", "via", "CD15", "also", "had", "posttranscriptional", "effects", ".", "Nuclear", "extracts", "of", "anti", "-", "CD15", "cross", "-", "linked", "cells", "demonstrated", "enhanced", "levels", "of", "the", "transcriptional", "factor", "activator", "protein-1", ",", "minimally", "changed", "nuclear", "factor", "-", "kappa", "B", ",", "and", "did", "not", "affect", "SV40", "promoter", "specific", "protein-1", ".", "We", "conclude", "that", "engagement", "of", "CD15", "on", "monocytes", "results", "in", "monocyte", "activation", ".", "In", "addition", "to", "its", "well", "-", "recognized", "adhesive", "role", ",", "CD15", "may", "function", "as", "an", "important", "signaling", "molecule", "capable", "of", "initiating", "proinflammatory", "events", "in", "monocytes", "that", "come", "into", "contact", "with", "activated", "endothelium", ".", "\n" ]
[ "Entity", "Protein" ]
tumor necrosis factor - alpha is a Protein, tissue factor is a Protein, CD36 is a Protein, endothelial selectins is a Protein, TNF - alpha is a Protein, TNF - alpha is a Protein, interleukin-1 beta is a Protein, IL-1 beta is a Protein, beta - actin is a Protein, cytokine genes is a Entity, CAT is a Protein, IL-1 beta is a Protein, promoter / enhancer sequences is a Entity, CAT is a Protein, IL-1 beta is a Protein, transcriptional factor activator protein-1 is a Entity, nuclear factor - kappa B is a Entity, SV40 promoter specific protein-1 is a Protein
394_1
Sentence: Engagement of the Lewis X antigen (CD15) results in monocyte activation. We previously reported that monocyte adhesion to tumor necrosis factor-alpha (TNF-alpha)-treated endothelial cells increased expression of tissue factor and CD36 on monocytes. Using immunological cross-linking to mimic receptor engagement by natural ligands, we now show that CD15 (Lewis X), a monocyte counter-receptor for endothelial selectins may participate in this response. We used cytokine production as a readout for monocyte activation and found that CD15 cross-linking induced TNF-alpha release from peripheral blood monocytes and cells from the monocytic cell line MM6. Quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) showed an increase in steady-state TNF-alpha mRNA after 3 to 4 hours of cross-linking. CD15 cross-linking also concomitantly increased interleukin-1 beta (IL-1 beta) mRNA, while no apparent change was observed in the levels of beta-actin mRNA, indicating specificity. To examine transcriptional regulation of cytokine genes by CD15 engagement, a CAT plasmid reporter construct containing IL-1 beta promoter/enhancer sequences was introduced into MM6. Subsequent cross-linking of CD15 increased CAT activity. CD15 engagement by monoclonal antibody also attenuated IL-1 beta transcript degradation, demonstrating that signaling via CD15 also had posttranscriptional effects. Nuclear extracts of anti-CD15 cross-linked cells demonstrated enhanced levels of the transcriptional factor activator protein-1, minimally changed nuclear factor-kappa B, and did not affect SV40 promoter specific protein-1. We conclude that engagement of CD15 on monocytes results in monocyte activation. In addition to its well-recognized adhesive role, CD15 may function as an important signaling molecule capable of initiating proinflammatory events in monocytes that come into contact with activated endothelium. Instructions: please typing these entity words according to sentence: tumor necrosis factor - alpha, tissue factor, CD36, endothelial selectins, TNF - alpha, TNF - alpha, interleukin-1 beta, IL-1 beta, beta - actin, cytokine genes, CAT, IL-1 beta, promoter / enhancer sequences, CAT, IL-1 beta, transcriptional factor activator protein-1, nuclear factor - kappa B, SV40 promoter specific protein-1 Options: Entity, Protein
[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "I-Protein", "I-Protein", "I-Protein", "I-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "I-Protein", "O", "B-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "I-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "I-Protein", "I-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "I-Protein", "I-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "I-Protein", "O", "B-Protein", "I-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "I-Protein", "I-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Entity", "I-Entity", "O", "O", "O", "O", "O", "B-Protein", "O", "O", "O", "O", "B-Protein", "I-Protein", "B-Entity", "I-Entity", "I-Entity", "I-Entity", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "I-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Entity", "I-Entity", "I-Entity", "I-Entity", "O", "O", "O", "B-Entity", "I-Entity", "I-Entity", "I-Entity", "I-Entity", "O", "O", "O", "O", "O", "B-Protein", "I-Protein", "I-Protein", "I-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ]
Engagement of the Lewis X antigen (CD15) results in monocyte activation. We previously reported that monocyte adhesion to tumor necrosis factor-alpha (TNF-alpha)-treated endothelial cells increased expression of tissue factor and CD36 on monocytes. Using immunological cross-linking to mimic receptor engagement by natural ligands, we now show that CD15 (Lewis X), a monocyte counter-receptor for endothelial selectins may participate in this response. We used cytokine production as a readout for monocyte activation and found that CD15 cross-linking induced TNF-alpha release from peripheral blood monocytes and cells from the monocytic cell line MM6. Quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) showed an increase in steady-state TNF-alpha mRNA after 3 to 4 hours of cross-linking. CD15 cross-linking also concomitantly increased interleukin-1 beta (IL-1 beta) mRNA, while no apparent change was observed in the levels of beta-actin mRNA, indicating specificity. To examine transcriptional regulation of cytokine genes by CD15 engagement, a CAT plasmid reporter construct containing IL-1 beta promoter/enhancer sequences was introduced into MM6. Subsequent cross-linking of CD15 increased CAT activity. CD15 engagement by monoclonal antibody also attenuated IL-1 beta transcript degradation, demonstrating that signaling via CD15 also had posttranscriptional effects. Nuclear extracts of anti-CD15 cross-linked cells demonstrated enhanced levels of the transcriptional factor activator protein-1, minimally changed nuclear factor-kappa B, and did not affect SV40 promoter specific protein-1. We conclude that engagement of CD15 on monocytes results in monocyte activation. In addition to its well-recognized adhesive role, CD15 may function as an important signaling molecule capable of initiating proinflammatory events in monocytes that come into contact with activated endothelium.
[ "Engagement", "of", "the", "Lewis", "X", "antigen", "(", "CD15", ")", "results", "in", "monocyte", "activation", ".", "\n", "We", "previously", "reported", "that", "monocyte", "adhesion", "to", "tumor", "necrosis", "factor", "-", "alpha", "(", "TNF", "-", "alpha)-treated", "endothelial", "cells", "increased", "expression", "of", "tissue", "factor", "and", "CD36", "on", "monocytes", ".", "Using", "immunological", "cross", "-", "linking", "to", "mimic", "receptor", "engagement", "by", "natural", "ligands", ",", "we", "now", "show", "that", "CD15", "(", "Lewis", "X", ")", ",", "a", "monocyte", "counter", "-", "receptor", "for", "endothelial", "selectins", "may", "participate", "in", "this", "response", ".", "We", "used", "cytokine", "production", "as", "a", "readout", "for", "monocyte", "activation", "and", "found", "that", "CD15", "cross", "-", "linking", "induced", "TNF", "-", "alpha", "release", "from", "peripheral", "blood", "monocytes", "and", "cells", "from", "the", "monocytic", "cell", "line", "MM6", ".", "Quantitative", "reverse", "transcriptase", "-", "polymerase", "chain", "reaction", "(", "RT", "-", "PCR", ")", "showed", "an", "increase", "in", "steady", "-", "state", "TNF", "-", "alpha", "mRNA", "after", "3", "to", "4", "hours", "of", "cross", "-", "linking", ".", "CD15", "cross", "-", "linking", "also", "concomitantly", "increased", "interleukin-1", "beta", "(", "IL-1", "beta", ")", "mRNA", ",", "while", "no", "apparent", "change", "was", "observed", "in", "the", "levels", "of", "beta", "-", "actin", "mRNA", ",", "indicating", "specificity", ".", "To", "examine", "transcriptional", "regulation", "of", "cytokine", "genes", "by", "CD15", "engagement", ",", "a", "CAT", "plasmid", "reporter", "construct", "containing", "IL-1", "beta", "promoter", "/", "enhancer", "sequences", "was", "introduced", "into", "MM6", ".", "Subsequent", "cross", "-", "linking", "of", "CD15", "increased", "CAT", "activity", ".", "CD15", "engagement", "by", "monoclonal", "antibody", "also", "attenuated", "IL-1", "beta", "transcript", "degradation", ",", "demonstrating", "that", "signaling", "via", "CD15", "also", "had", "posttranscriptional", "effects", ".", "Nuclear", "extracts", "of", "anti", "-", "CD15", "cross", "-", "linked", "cells", "demonstrated", "enhanced", "levels", "of", "the", "transcriptional", "factor", "activator", "protein-1", ",", "minimally", "changed", "nuclear", "factor", "-", "kappa", "B", ",", "and", "did", "not", "affect", "SV40", "promoter", "specific", "protein-1", ".", "We", "conclude", "that", "engagement", "of", "CD15", "on", "monocytes", "results", "in", "monocyte", "activation", ".", "In", "addition", "to", "its", "well", "-", "recognized", "adhesive", "role", ",", "CD15", "may", "function", "as", "an", "important", "signaling", "molecule", "capable", "of", "initiating", "proinflammatory", "events", "in", "monocytes", "that", "come", "into", "contact", "with", "activated", "endothelium", ".", "\n" ]
[ "Entity", "Protein" ]
tumor necrosis factor - alpha, tissue factor, CD36, endothelial selectins, TNF - alpha, TNF - alpha, interleukin-1 beta, IL-1 beta, beta - actin, cytokine genes, CAT, IL-1 beta, promoter / enhancer sequences, CAT, IL-1 beta, transcriptional factor activator protein-1, nuclear factor - kappa B, SV40 promoter specific protein-1
394_2
Sentence: Engagement of the Lewis X antigen (CD15) results in monocyte activation. We previously reported that monocyte adhesion to tumor necrosis factor-alpha (TNF-alpha)-treated endothelial cells increased expression of tissue factor and CD36 on monocytes. Using immunological cross-linking to mimic receptor engagement by natural ligands, we now show that CD15 (Lewis X), a monocyte counter-receptor for endothelial selectins may participate in this response. We used cytokine production as a readout for monocyte activation and found that CD15 cross-linking induced TNF-alpha release from peripheral blood monocytes and cells from the monocytic cell line MM6. Quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) showed an increase in steady-state TNF-alpha mRNA after 3 to 4 hours of cross-linking. CD15 cross-linking also concomitantly increased interleukin-1 beta (IL-1 beta) mRNA, while no apparent change was observed in the levels of beta-actin mRNA, indicating specificity. To examine transcriptional regulation of cytokine genes by CD15 engagement, a CAT plasmid reporter construct containing IL-1 beta promoter/enhancer sequences was introduced into MM6. Subsequent cross-linking of CD15 increased CAT activity. CD15 engagement by monoclonal antibody also attenuated IL-1 beta transcript degradation, demonstrating that signaling via CD15 also had posttranscriptional effects. Nuclear extracts of anti-CD15 cross-linked cells demonstrated enhanced levels of the transcriptional factor activator protein-1, minimally changed nuclear factor-kappa B, and did not affect SV40 promoter specific protein-1. We conclude that engagement of CD15 on monocytes results in monocyte activation. In addition to its well-recognized adhesive role, CD15 may function as an important signaling molecule capable of initiating proinflammatory events in monocytes that come into contact with activated endothelium. Instructions: please extract entity words from the input sentence
[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "I-Protein", "I-Protein", "I-Protein", "I-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "I-Protein", "O", "B-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "I-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "I-Protein", "I-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "I-Protein", "I-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "I-Protein", "O", "B-Protein", "I-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "I-Protein", "I-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Entity", "I-Entity", "O", "O", "O", "O", "O", "B-Protein", "O", "O", "O", "O", "B-Protein", "I-Protein", "B-Entity", "I-Entity", "I-Entity", "I-Entity", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "I-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Entity", "I-Entity", "I-Entity", "I-Entity", "O", "O", "O", "B-Entity", "I-Entity", "I-Entity", "I-Entity", "I-Entity", "O", "O", "O", "O", "O", "B-Protein", "I-Protein", "I-Protein", "I-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ]
Engagement of the Lewis X antigen (CD15) results in monocyte activation. We previously reported that monocyte adhesion to tumor necrosis factor-alpha (TNF-alpha)-treated endothelial cells increased expression of tissue factor and CD36 on monocytes. Using immunological cross-linking to mimic receptor engagement by natural ligands, we now show that CD15 (Lewis X), a monocyte counter-receptor for endothelial selectins may participate in this response. We used cytokine production as a readout for monocyte activation and found that CD15 cross-linking induced TNF-alpha release from peripheral blood monocytes and cells from the monocytic cell line MM6. Quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) showed an increase in steady-state TNF-alpha mRNA after 3 to 4 hours of cross-linking. CD15 cross-linking also concomitantly increased interleukin-1 beta (IL-1 beta) mRNA, while no apparent change was observed in the levels of beta-actin mRNA, indicating specificity. To examine transcriptional regulation of cytokine genes by CD15 engagement, a CAT plasmid reporter construct containing IL-1 beta promoter/enhancer sequences was introduced into MM6. Subsequent cross-linking of CD15 increased CAT activity. CD15 engagement by monoclonal antibody also attenuated IL-1 beta transcript degradation, demonstrating that signaling via CD15 also had posttranscriptional effects. Nuclear extracts of anti-CD15 cross-linked cells demonstrated enhanced levels of the transcriptional factor activator protein-1, minimally changed nuclear factor-kappa B, and did not affect SV40 promoter specific protein-1. We conclude that engagement of CD15 on monocytes results in monocyte activation. In addition to its well-recognized adhesive role, CD15 may function as an important signaling molecule capable of initiating proinflammatory events in monocytes that come into contact with activated endothelium.
[ "Engagement", "of", "the", "Lewis", "X", "antigen", "(", "CD15", ")", "results", "in", "monocyte", "activation", ".", "\n", "We", "previously", "reported", "that", "monocyte", "adhesion", "to", "tumor", "necrosis", "factor", "-", "alpha", "(", "TNF", "-", "alpha)-treated", "endothelial", "cells", "increased", "expression", "of", "tissue", "factor", "and", "CD36", "on", "monocytes", ".", "Using", "immunological", "cross", "-", "linking", "to", "mimic", "receptor", "engagement", "by", "natural", "ligands", ",", "we", "now", "show", "that", "CD15", "(", "Lewis", "X", ")", ",", "a", "monocyte", "counter", "-", "receptor", "for", "endothelial", "selectins", "may", "participate", "in", "this", "response", ".", "We", "used", "cytokine", "production", "as", "a", "readout", "for", "monocyte", "activation", "and", "found", "that", "CD15", "cross", "-", "linking", "induced", "TNF", "-", "alpha", "release", "from", "peripheral", "blood", "monocytes", "and", "cells", "from", "the", "monocytic", "cell", "line", "MM6", ".", "Quantitative", "reverse", "transcriptase", "-", "polymerase", "chain", "reaction", "(", "RT", "-", "PCR", ")", "showed", "an", "increase", "in", "steady", "-", "state", "TNF", "-", "alpha", "mRNA", "after", "3", "to", "4", "hours", "of", "cross", "-", "linking", ".", "CD15", "cross", "-", "linking", "also", "concomitantly", "increased", "interleukin-1", "beta", "(", "IL-1", "beta", ")", "mRNA", ",", "while", "no", "apparent", "change", "was", "observed", "in", "the", "levels", "of", "beta", "-", "actin", "mRNA", ",", "indicating", "specificity", ".", "To", "examine", "transcriptional", "regulation", "of", "cytokine", "genes", "by", "CD15", "engagement", ",", "a", "CAT", "plasmid", "reporter", "construct", "containing", "IL-1", "beta", "promoter", "/", "enhancer", "sequences", "was", "introduced", "into", "MM6", ".", "Subsequent", "cross", "-", "linking", "of", "CD15", "increased", "CAT", "activity", ".", "CD15", "engagement", "by", "monoclonal", "antibody", "also", "attenuated", "IL-1", "beta", "transcript", "degradation", ",", "demonstrating", "that", "signaling", "via", "CD15", "also", "had", "posttranscriptional", "effects", ".", "Nuclear", "extracts", "of", "anti", "-", "CD15", "cross", "-", "linked", "cells", "demonstrated", "enhanced", "levels", "of", "the", "transcriptional", "factor", "activator", "protein-1", ",", "minimally", "changed", "nuclear", "factor", "-", "kappa", "B", ",", "and", "did", "not", "affect", "SV40", "promoter", "specific", "protein-1", ".", "We", "conclude", "that", "engagement", "of", "CD15", "on", "monocytes", "results", "in", "monocyte", "activation", ".", "In", "addition", "to", "its", "well", "-", "recognized", "adhesive", "role", ",", "CD15", "may", "function", "as", "an", "important", "signaling", "molecule", "capable", "of", "initiating", "proinflammatory", "events", "in", "monocytes", "that", "come", "into", "contact", "with", "activated", "endothelium", ".", "\n" ]
[ "Entity", "Protein" ]
CXCL8 is a Protein, the levels is a Anaphora, IL-6 is a Protein, IL-6 is a Protein
183_0
Sentence: Involvement of NF-kappaB in cytokine regulation. Cytokine/chemokine levels were determined using ELISA following incubation of Jurkat T-cells with NAI (1 h) and stimulation (24 h). (A) CXCL8 expression was partially inhibited following PMA stimulation (grey bars), whereas the levels were not altered following stimulation with HK E. coli (black bars), this indicates an induction mainly regulated by AP-1. (B) TNF expression was not affected by NAI. (C) IL-6 release was completely inhibited by NAI following PMA exposure, indicating regulation through NF-kappaB since IL-6 expression was significantly increased in response to HK E. coli than PMA. Statistical significance from the positive control (PMA/HK E. coli) was determined using Student's t-test. (n = 3). Instructions: please extract entities and their types from the input sentence, all entity types are in options Options: Protein, Anaphora
[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Anaphora", "I-Anaphora", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ]
Involvement of NF-kappaB in cytokine regulation. Cytokine/chemokine levels were determined using ELISA following incubation of Jurkat T-cells with NAI (1 h) and stimulation (24 h). (A) CXCL8 expression was partially inhibited following PMA stimulation (grey bars), whereas the levels were not altered following stimulation with HK E. coli (black bars), this indicates an induction mainly regulated by AP-1. (B) TNF expression was not affected by NAI. (C) IL-6 release was completely inhibited by NAI following PMA exposure, indicating regulation through NF-kappaB since IL-6 expression was significantly increased in response to HK E. coli than PMA. Statistical significance from the positive control (PMA/HK E. coli) was determined using Student's t-test. (n = 3).
[ "Involvement", "of", "NF", "-", "kappaB", "in", "cytokine", "regulation", ".", "Cytokine", "/", "chemokine", "levels", "were", "determined", "using", "ELISA", "following", "incubation", "of", "Jurkat", "T", "-", "cells", "with", "NAI", "(", "1", "h", ")", "and", "stimulation", "(", "24", "h", ")", ".", "(", "A", ")", "CXCL8", "expression", "was", "partially", "inhibited", "following", "PMA", "stimulation", "(", "grey", "bars", ")", ",", "whereas", "the", "levels", "were", "not", "altered", "following", "stimulation", "with", "HK", "E.", "coli", "(", "black", "bars", ")", ",", "this", "indicates", "an", "induction", "mainly", "regulated", "by", "AP-1", ".", "(", "B", ")", "TNF", "expression", "was", "not", "affected", "by", "NAI", ".", "(", "C", ")", "IL-6", "release", "was", "completely", "inhibited", "by", "NAI", "following", "PMA", "exposure", ",", "indicating", "regulation", "through", "NF", "-", "kappaB", "since", "IL-6", "expression", "was", "significantly", "increased", "in", "response", "to", "HK", "E.", "coli", "than", "PMA", ".", "Statistical", "significance", "from", "the", "positive", "control", "(", "PMA", "/", "HK", "E.", "coli", ")", "was", "determined", "using", "Student", "'s", "t", "-", "test", ".", "(", "n", "=", "3", ")", "." ]
[ "Anaphora", "Protein" ]
CXCL8 is a Protein, the levels is a Anaphora, IL-6 is a Protein, IL-6 is a Protein
183_1
Sentence: Involvement of NF-kappaB in cytokine regulation. Cytokine/chemokine levels were determined using ELISA following incubation of Jurkat T-cells with NAI (1 h) and stimulation (24 h). (A) CXCL8 expression was partially inhibited following PMA stimulation (grey bars), whereas the levels were not altered following stimulation with HK E. coli (black bars), this indicates an induction mainly regulated by AP-1. (B) TNF expression was not affected by NAI. (C) IL-6 release was completely inhibited by NAI following PMA exposure, indicating regulation through NF-kappaB since IL-6 expression was significantly increased in response to HK E. coli than PMA. Statistical significance from the positive control (PMA/HK E. coli) was determined using Student's t-test. (n = 3). Instructions: please typing these entity words according to sentence: CXCL8, the levels, IL-6, IL-6 Options: Protein, Anaphora
[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Anaphora", "I-Anaphora", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ]
Involvement of NF-kappaB in cytokine regulation. Cytokine/chemokine levels were determined using ELISA following incubation of Jurkat T-cells with NAI (1 h) and stimulation (24 h). (A) CXCL8 expression was partially inhibited following PMA stimulation (grey bars), whereas the levels were not altered following stimulation with HK E. coli (black bars), this indicates an induction mainly regulated by AP-1. (B) TNF expression was not affected by NAI. (C) IL-6 release was completely inhibited by NAI following PMA exposure, indicating regulation through NF-kappaB since IL-6 expression was significantly increased in response to HK E. coli than PMA. Statistical significance from the positive control (PMA/HK E. coli) was determined using Student's t-test. (n = 3).
[ "Involvement", "of", "NF", "-", "kappaB", "in", "cytokine", "regulation", ".", "Cytokine", "/", "chemokine", "levels", "were", "determined", "using", "ELISA", "following", "incubation", "of", "Jurkat", "T", "-", "cells", "with", "NAI", "(", "1", "h", ")", "and", "stimulation", "(", "24", "h", ")", ".", "(", "A", ")", "CXCL8", "expression", "was", "partially", "inhibited", "following", "PMA", "stimulation", "(", "grey", "bars", ")", ",", "whereas", "the", "levels", "were", "not", "altered", "following", "stimulation", "with", "HK", "E.", "coli", "(", "black", "bars", ")", ",", "this", "indicates", "an", "induction", "mainly", "regulated", "by", "AP-1", ".", "(", "B", ")", "TNF", "expression", "was", "not", "affected", "by", "NAI", ".", "(", "C", ")", "IL-6", "release", "was", "completely", "inhibited", "by", "NAI", "following", "PMA", "exposure", ",", "indicating", "regulation", "through", "NF", "-", "kappaB", "since", "IL-6", "expression", "was", "significantly", "increased", "in", "response", "to", "HK", "E.", "coli", "than", "PMA", ".", "Statistical", "significance", "from", "the", "positive", "control", "(", "PMA", "/", "HK", "E.", "coli", ")", "was", "determined", "using", "Student", "'s", "t", "-", "test", ".", "(", "n", "=", "3", ")", "." ]
[ "Anaphora", "Protein" ]
CXCL8, the levels, IL-6, IL-6
183_2
Sentence: Involvement of NF-kappaB in cytokine regulation. Cytokine/chemokine levels were determined using ELISA following incubation of Jurkat T-cells with NAI (1 h) and stimulation (24 h). (A) CXCL8 expression was partially inhibited following PMA stimulation (grey bars), whereas the levels were not altered following stimulation with HK E. coli (black bars), this indicates an induction mainly regulated by AP-1. (B) TNF expression was not affected by NAI. (C) IL-6 release was completely inhibited by NAI following PMA exposure, indicating regulation through NF-kappaB since IL-6 expression was significantly increased in response to HK E. coli than PMA. Statistical significance from the positive control (PMA/HK E. coli) was determined using Student's t-test. (n = 3). Instructions: please extract entity words from the input sentence
[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Anaphora", "I-Anaphora", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ]
Involvement of NF-kappaB in cytokine regulation. Cytokine/chemokine levels were determined using ELISA following incubation of Jurkat T-cells with NAI (1 h) and stimulation (24 h). (A) CXCL8 expression was partially inhibited following PMA stimulation (grey bars), whereas the levels were not altered following stimulation with HK E. coli (black bars), this indicates an induction mainly regulated by AP-1. (B) TNF expression was not affected by NAI. (C) IL-6 release was completely inhibited by NAI following PMA exposure, indicating regulation through NF-kappaB since IL-6 expression was significantly increased in response to HK E. coli than PMA. Statistical significance from the positive control (PMA/HK E. coli) was determined using Student's t-test. (n = 3).
[ "Involvement", "of", "NF", "-", "kappaB", "in", "cytokine", "regulation", ".", "Cytokine", "/", "chemokine", "levels", "were", "determined", "using", "ELISA", "following", "incubation", "of", "Jurkat", "T", "-", "cells", "with", "NAI", "(", "1", "h", ")", "and", "stimulation", "(", "24", "h", ")", ".", "(", "A", ")", "CXCL8", "expression", "was", "partially", "inhibited", "following", "PMA", "stimulation", "(", "grey", "bars", ")", ",", "whereas", "the", "levels", "were", "not", "altered", "following", "stimulation", "with", "HK", "E.", "coli", "(", "black", "bars", ")", ",", "this", "indicates", "an", "induction", "mainly", "regulated", "by", "AP-1", ".", "(", "B", ")", "TNF", "expression", "was", "not", "affected", "by", "NAI", ".", "(", "C", ")", "IL-6", "release", "was", "completely", "inhibited", "by", "NAI", "following", "PMA", "exposure", ",", "indicating", "regulation", "through", "NF", "-", "kappaB", "since", "IL-6", "expression", "was", "significantly", "increased", "in", "response", "to", "HK", "E.", "coli", "than", "PMA", ".", "Statistical", "significance", "from", "the", "positive", "control", "(", "PMA", "/", "HK", "E.", "coli", ")", "was", "determined", "using", "Student", "'s", "t", "-", "test", ".", "(", "n", "=", "3", ")", "." ]
[ "Anaphora", "Protein" ]
Maritza is a NOMBRE_SUJETO_ASISTENCIA, Sanchez de Miguel is a NOMBRE_SUJETO_ASISTENCIA, 8374542 is a ID_SUJETO_ASISTENCIA, 89 32670766 01 is a ID_ASEGURAMIENTO, Calle del Aguacate , 44 is a CALLE, Madrid is a TERRITORIO, 28040 is a TERRITORIO, 20/07/1956 is a FECHAS, Espa帽a is a PAIS, 54 a帽os is a EDAD_SUJETO_ASISTENCIA, 31/05/2011 is a FECHAS, Elias Mor谩n Pascual is a NOMBRE_PERSONAL_SANITARIO, 28 28 91467 is a ID_TITULACION_PERSONAL_SANITARIO, femenino is a SEXO_SUJETO_ASISTENCIA, 54 a帽os is a EDAD_SUJETO_ASISTENCIA, Elias Mor谩n Pascual is a NOMBRE_PERSONAL_SANITARIO, averquetedigo@hotmail.com is a CORREO_ELECTRONICO
353_0
Sentence: Datos del paciente. Nombre: Maritza. Apellidos: Sanchez de Miguel. NHC: 8374542. NASS: 89 32670766 01. Domicilio: Calle del Aguacate, 44. Localidad/ Provincia: Madrid. CP: 28040. Datos asistenciales. Fecha de nacimiento: 20/07/1956. Pa铆s de nacimiento: Espa帽a. Edad: 54 a帽os Sexo: M. Fecha de Ingreso: 31/05/2011. M茅dico: Elias Mor谩n Pascual N潞Col: 28 28 91467. Informe cl铆nico del paciente: paciente de sexo femenino, de 54 a帽os de edad, diagnosticada con edentulismo parcial de ambas arcadas y atrofia alveolar severa clase III de Seibert1 en la regi贸n de premaxila ed茅ntula. El plan del tratamiento consiste en la colocaci贸n de 2 perlas de hidrogel esterilizadas en autoclave para la expansi贸n tisular de la premaxila, y un posterior aloinjerto 贸seo en bloque en el mismo lugar. Dos semanas despu茅s de la colocaci贸n de las perlas de hidrogel, se realiza la exposici贸n y retirada de las mismas, con colocaci贸n de bloques de aloinjerto marca Biograft庐, preformados transquirurgicamente por medio de estereolitograf铆a, se pudo realizar el cierre de la herida sin tensi贸n y sin la necesidad de realizar descargas al colgajo, ni incisiones para liberar tensi贸n del periostio. Una vez culminado el periodo de oseointegraci贸n del bloque (aproximadamente 6 meses), se realiza la colocaci贸n de los implantes dentales, planeados inicialmente en una adecuada posici贸n, con muy buen tejido 贸seo y blando para su rehabilitaci贸n. Responsable cl铆nico: Elias Mor谩n Pascual. email: averquetedigo@hotmail.com Instructions: please extract entities and their types from the input sentence, all entity types are in options Options: ID_TITULACION_PERSONAL_SANITARIO, TERRITORIO, ID_SUJETO_ASISTENCIA, FECHAS, SEXO_SUJETO_ASISTENCIA, CALLE, NOMBRE_SUJETO_ASISTENCIA, PAIS, CORREO_ELECTRONICO, EDAD_SUJETO_ASISTENCIA, NOMBRE_PERSONAL_SANITARIO, ID_ASEGURAMIENTO
[ "O", "O", "O", "O", "O", "O", "O", "B-NOMBRE_SUJETO_ASISTENCIA", "O", "O", "O", "O", "B-NOMBRE_SUJETO_ASISTENCIA", "I-NOMBRE_SUJETO_ASISTENCIA", "I-NOMBRE_SUJETO_ASISTENCIA", "O", "O", "O", "O", "B-ID_SUJETO_ASISTENCIA", "O", "O", "O", "O", "B-ID_ASEGURAMIENTO", "I-ID_ASEGURAMIENTO", "I-ID_ASEGURAMIENTO", "O", "O", "O", "O", "B-CALLE", "I-CALLE", "I-CALLE", "I-CALLE", "I-CALLE", "O", "O", "O", "O", "O", "B-TERRITORIO", "O", "O", "O", "O", "B-TERRITORIO", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-FECHAS", "O", "O", "O", "O", "O", "O", "B-PAIS", "O", "O", "O", "O", "B-EDAD_SUJETO_ASISTENCIA", "I-EDAD_SUJETO_ASISTENCIA", "O", "O", "O", "O", "O", "O", "O", "O", "B-FECHAS", "O", "O", "O", "O", "B-NOMBRE_PERSONAL_SANITARIO", "I-NOMBRE_PERSONAL_SANITARIO", "I-NOMBRE_PERSONAL_SANITARIO", "O", "O", "O", "B-ID_TITULACION_PERSONAL_SANITARIO", "I-ID_TITULACION_PERSONAL_SANITARIO", "I-ID_TITULACION_PERSONAL_SANITARIO", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-SEXO_SUJETO_ASISTENCIA", "O", "O", "B-EDAD_SUJETO_ASISTENCIA", "I-EDAD_SUJETO_ASISTENCIA", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-NOMBRE_PERSONAL_SANITARIO", "I-NOMBRE_PERSONAL_SANITARIO", "I-NOMBRE_PERSONAL_SANITARIO", "O", "O", "O", "O", "B-CORREO_ELECTRONICO", "O" ]
Datos del paciente. Nombre: Maritza. Apellidos: Sanchez de Miguel. NHC: 8374542. NASS: 89 32670766 01. Domicilio: Calle del Aguacate, 44. Localidad/ Provincia: Madrid. CP: 28040. Datos asistenciales. Fecha de nacimiento: 20/07/1956. Pa铆s de nacimiento: Espa帽a. Edad: 54 a帽os Sexo: M. Fecha de Ingreso: 31/05/2011. M茅dico: Elias Mor谩n Pascual N潞Col: 28 28 91467. Informe cl铆nico del paciente: paciente de sexo femenino, de 54 a帽os de edad, diagnosticada con edentulismo parcial de ambas arcadas y atrofia alveolar severa clase III de Seibert1 en la regi贸n de premaxila ed茅ntula. El plan del tratamiento consiste en la colocaci贸n de 2 perlas de hidrogel esterilizadas en autoclave para la expansi贸n tisular de la premaxila, y un posterior aloinjerto 贸seo en bloque en el mismo lugar. Dos semanas despu茅s de la colocaci贸n de las perlas de hidrogel, se realiza la exposici贸n y retirada de las mismas, con colocaci贸n de bloques de aloinjerto marca Biograft庐, preformados transquirurgicamente por medio de estereolitograf铆a, se pudo realizar el cierre de la herida sin tensi贸n y sin la necesidad de realizar descargas al colgajo, ni incisiones para liberar tensi贸n del periostio. Una vez culminado el periodo de oseointegraci贸n del bloque (aproximadamente 6 meses), se realiza la colocaci贸n de los implantes dentales, planeados inicialmente en una adecuada posici贸n, con muy buen tejido 贸seo y blando para su rehabilitaci贸n. Responsable cl铆nico: Elias Mor谩n Pascual. email: averquetedigo@hotmail.com
[ "Datos", "del", "paciente", ".", "\n", "Nombre", ":", "Maritza", ".", "\n", "Apellidos", ":", "Sanchez", "de", "Miguel", ".", "\n", "NHC", ":", "8374542", ".", "\n", "NASS", ":", "89", "32670766", "01", ".", "\n", "Domicilio", ":", "Calle", "del", "Aguacate", ",", "44", ".", "\n", "Localidad/", "Provincia", ":", "Madrid", ".", "\n", "CP", ":", "28040", ".", "\n", "Datos", "asistenciales", ".", "\n", "Fecha", "de", "nacimiento", ":", "20/07/1956", ".", "\n", "Pa铆s", "de", "nacimiento", ":", "Espa帽a", ".", "\n", "Edad", ":", "54", "a帽os", "Sexo", ":", "M.", "\n", "Fecha", "de", "Ingreso", ":", "31/05/2011", ".", "\n", "M茅dico", ":", "Elias", "Mor谩n", "Pascual", " ", "N潞Col", ":", "28", "28", "91467", ".", "\n", "Informe", "cl铆nico", "del", "paciente", ":", "paciente", "de", "sexo", "femenino", ",", "de", "54", "a帽os", "de", "edad", ",", "diagnosticada", "con", "edentulismo", "parcial", "de", "ambas", "arcadas", "y", "atrofia", "alveolar", "severa", "clase", "III", "de", "Seibert1", "en", "la", "regi贸n", "de", "premaxila", "ed茅ntula", ".", "\n", "El", "plan", "del", "tratamiento", "consiste", "en", "la", "colocaci贸n", "de", "2", "perlas", "de", "hidrogel", "esterilizadas", "en", "autoclave", "para", "la", "expansi贸n", "tisular", "de", "la", "premaxila", ",", "y", "un", "posterior", "aloinjerto", "贸seo", "en", "bloque", "en", "el", "mismo", "lugar", ".", "\n", "Dos", "semanas", "despu茅s", "de", "la", "colocaci贸n", "de", "las", "perlas", "de", "hidrogel", ",", "se", "realiza", "la", "exposici贸n", "y", "retirada", "de", "las", "mismas", ",", "con", "colocaci贸n", "de", "bloques", "de", "aloinjerto", "marca", "Biograft", "庐", ",", "preformados", "transquirurgicamente", "por", "medio", "de", "estereolitograf铆a", ",", "se", "pudo", "realizar", "el", "cierre", "de", "la", "herida", "sin", "tensi贸n", "y", "sin", "la", "necesidad", "de", "realizar", "descargas", "al", "colgajo", ",", "ni", "incisiones", "para", "liberar", "tensi贸n", "del", "periostio", ".", "\n", "Una", "vez", "culminado", "el", "periodo", "de", "oseointegraci贸n", "del", "bloque", "(", "aproximadamente", "6", "meses", ")", ",", "se", "realiza", "la", "colocaci贸n", "de", "los", "implantes", "dentales", ",", "planeados", "inicialmente", "en", "una", "adecuada", "posici贸n", ",", "con", "muy", "buen", "tejido", "贸seo", "y", "blando", "para", "su", "rehabilitaci贸n", ".", "\n", "Responsable", "cl铆nico", ":", "Elias", "Mor谩n", "Pascual", ".", "email", ":", " ", "averquetedigo@hotmail.com", "\n" ]
[ "CORREO_ELECTRONICO", "CALLE", "NOMBRE_PERSONAL_SANITARIO", "NOMBRE_SUJETO_ASISTENCIA", "ID_ASEGURAMIENTO", "ID_TITULACION_PERSONAL_SANITARIO", "FECHAS", "SEXO_SUJETO_ASISTENCIA", "EDAD_SUJETO_ASISTENCIA", "ID_SUJETO_ASISTENCIA", "PAIS", "TERRITORIO" ]
Maritza is a NOMBRE_SUJETO_ASISTENCIA, Sanchez de Miguel is a NOMBRE_SUJETO_ASISTENCIA, 8374542 is a ID_SUJETO_ASISTENCIA, 89 32670766 01 is a ID_ASEGURAMIENTO, Calle del Aguacate , 44 is a CALLE, Madrid is a TERRITORIO, 28040 is a TERRITORIO, 20/07/1956 is a FECHAS, Espa帽a is a PAIS, 54 a帽os is a EDAD_SUJETO_ASISTENCIA, 31/05/2011 is a FECHAS, Elias Mor谩n Pascual is a NOMBRE_PERSONAL_SANITARIO, 28 28 91467 is a ID_TITULACION_PERSONAL_SANITARIO, femenino is a SEXO_SUJETO_ASISTENCIA, 54 a帽os is a EDAD_SUJETO_ASISTENCIA, Elias Mor谩n Pascual is a NOMBRE_PERSONAL_SANITARIO, averquetedigo@hotmail.com is a CORREO_ELECTRONICO
353_1
Sentence: Datos del paciente. Nombre: Maritza. Apellidos: Sanchez de Miguel. NHC: 8374542. NASS: 89 32670766 01. Domicilio: Calle del Aguacate, 44. Localidad/ Provincia: Madrid. CP: 28040. Datos asistenciales. Fecha de nacimiento: 20/07/1956. Pa铆s de nacimiento: Espa帽a. Edad: 54 a帽os Sexo: M. Fecha de Ingreso: 31/05/2011. M茅dico: Elias Mor谩n Pascual N潞Col: 28 28 91467. Informe cl铆nico del paciente: paciente de sexo femenino, de 54 a帽os de edad, diagnosticada con edentulismo parcial de ambas arcadas y atrofia alveolar severa clase III de Seibert1 en la regi贸n de premaxila ed茅ntula. El plan del tratamiento consiste en la colocaci贸n de 2 perlas de hidrogel esterilizadas en autoclave para la expansi贸n tisular de la premaxila, y un posterior aloinjerto 贸seo en bloque en el mismo lugar. Dos semanas despu茅s de la colocaci贸n de las perlas de hidrogel, se realiza la exposici贸n y retirada de las mismas, con colocaci贸n de bloques de aloinjerto marca Biograft庐, preformados transquirurgicamente por medio de estereolitograf铆a, se pudo realizar el cierre de la herida sin tensi贸n y sin la necesidad de realizar descargas al colgajo, ni incisiones para liberar tensi贸n del periostio. Una vez culminado el periodo de oseointegraci贸n del bloque (aproximadamente 6 meses), se realiza la colocaci贸n de los implantes dentales, planeados inicialmente en una adecuada posici贸n, con muy buen tejido 贸seo y blando para su rehabilitaci贸n. Responsable cl铆nico: Elias Mor谩n Pascual. email: averquetedigo@hotmail.com Instructions: please typing these entity words according to sentence: Maritza, Sanchez de Miguel, 8374542, 89 32670766 01, Calle del Aguacate , 44, Madrid, 28040, 20/07/1956, Espa帽a, 54 a帽os, 31/05/2011, Elias Mor谩n Pascual, 28 28 91467, femenino, 54 a帽os, Elias Mor谩n Pascual, averquetedigo@hotmail.com Options: ID_TITULACION_PERSONAL_SANITARIO, TERRITORIO, ID_SUJETO_ASISTENCIA, FECHAS, SEXO_SUJETO_ASISTENCIA, CALLE, NOMBRE_SUJETO_ASISTENCIA, PAIS, CORREO_ELECTRONICO, EDAD_SUJETO_ASISTENCIA, NOMBRE_PERSONAL_SANITARIO, ID_ASEGURAMIENTO
[ "O", "O", "O", "O", "O", "O", "O", "B-NOMBRE_SUJETO_ASISTENCIA", "O", "O", "O", "O", "B-NOMBRE_SUJETO_ASISTENCIA", "I-NOMBRE_SUJETO_ASISTENCIA", "I-NOMBRE_SUJETO_ASISTENCIA", "O", "O", "O", "O", "B-ID_SUJETO_ASISTENCIA", "O", "O", "O", "O", "B-ID_ASEGURAMIENTO", "I-ID_ASEGURAMIENTO", "I-ID_ASEGURAMIENTO", "O", "O", "O", "O", "B-CALLE", "I-CALLE", "I-CALLE", "I-CALLE", "I-CALLE", "O", "O", "O", "O", "O", "B-TERRITORIO", "O", "O", "O", "O", "B-TERRITORIO", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-FECHAS", "O", "O", "O", "O", "O", "O", "B-PAIS", "O", "O", "O", "O", "B-EDAD_SUJETO_ASISTENCIA", "I-EDAD_SUJETO_ASISTENCIA", "O", "O", "O", "O", "O", "O", "O", "O", "B-FECHAS", "O", "O", "O", "O", "B-NOMBRE_PERSONAL_SANITARIO", "I-NOMBRE_PERSONAL_SANITARIO", "I-NOMBRE_PERSONAL_SANITARIO", "O", "O", "O", "B-ID_TITULACION_PERSONAL_SANITARIO", "I-ID_TITULACION_PERSONAL_SANITARIO", "I-ID_TITULACION_PERSONAL_SANITARIO", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-SEXO_SUJETO_ASISTENCIA", "O", "O", "B-EDAD_SUJETO_ASISTENCIA", "I-EDAD_SUJETO_ASISTENCIA", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-NOMBRE_PERSONAL_SANITARIO", "I-NOMBRE_PERSONAL_SANITARIO", "I-NOMBRE_PERSONAL_SANITARIO", "O", "O", "O", "O", "B-CORREO_ELECTRONICO", "O" ]
Datos del paciente. Nombre: Maritza. Apellidos: Sanchez de Miguel. NHC: 8374542. NASS: 89 32670766 01. Domicilio: Calle del Aguacate, 44. Localidad/ Provincia: Madrid. CP: 28040. Datos asistenciales. Fecha de nacimiento: 20/07/1956. Pa铆s de nacimiento: Espa帽a. Edad: 54 a帽os Sexo: M. Fecha de Ingreso: 31/05/2011. M茅dico: Elias Mor谩n Pascual N潞Col: 28 28 91467. Informe cl铆nico del paciente: paciente de sexo femenino, de 54 a帽os de edad, diagnosticada con edentulismo parcial de ambas arcadas y atrofia alveolar severa clase III de Seibert1 en la regi贸n de premaxila ed茅ntula. El plan del tratamiento consiste en la colocaci贸n de 2 perlas de hidrogel esterilizadas en autoclave para la expansi贸n tisular de la premaxila, y un posterior aloinjerto 贸seo en bloque en el mismo lugar. Dos semanas despu茅s de la colocaci贸n de las perlas de hidrogel, se realiza la exposici贸n y retirada de las mismas, con colocaci贸n de bloques de aloinjerto marca Biograft庐, preformados transquirurgicamente por medio de estereolitograf铆a, se pudo realizar el cierre de la herida sin tensi贸n y sin la necesidad de realizar descargas al colgajo, ni incisiones para liberar tensi贸n del periostio. Una vez culminado el periodo de oseointegraci贸n del bloque (aproximadamente 6 meses), se realiza la colocaci贸n de los implantes dentales, planeados inicialmente en una adecuada posici贸n, con muy buen tejido 贸seo y blando para su rehabilitaci贸n. Responsable cl铆nico: Elias Mor谩n Pascual. email: averquetedigo@hotmail.com
[ "Datos", "del", "paciente", ".", "\n", "Nombre", ":", "Maritza", ".", "\n", "Apellidos", ":", "Sanchez", "de", "Miguel", ".", "\n", "NHC", ":", "8374542", ".", "\n", "NASS", ":", "89", "32670766", "01", ".", "\n", "Domicilio", ":", "Calle", "del", "Aguacate", ",", "44", ".", "\n", "Localidad/", "Provincia", ":", "Madrid", ".", "\n", "CP", ":", "28040", ".", "\n", "Datos", "asistenciales", ".", "\n", "Fecha", "de", "nacimiento", ":", "20/07/1956", ".", "\n", "Pa铆s", "de", "nacimiento", ":", "Espa帽a", ".", "\n", "Edad", ":", "54", "a帽os", "Sexo", ":", "M.", "\n", "Fecha", "de", "Ingreso", ":", "31/05/2011", ".", "\n", "M茅dico", ":", "Elias", "Mor谩n", "Pascual", " ", "N潞Col", ":", "28", "28", "91467", ".", "\n", "Informe", "cl铆nico", "del", "paciente", ":", "paciente", "de", "sexo", "femenino", ",", "de", "54", "a帽os", "de", "edad", ",", "diagnosticada", "con", "edentulismo", "parcial", "de", "ambas", "arcadas", "y", "atrofia", "alveolar", "severa", "clase", "III", "de", "Seibert1", "en", "la", "regi贸n", "de", "premaxila", "ed茅ntula", ".", "\n", "El", "plan", "del", "tratamiento", "consiste", "en", "la", "colocaci贸n", "de", "2", "perlas", "de", "hidrogel", "esterilizadas", "en", "autoclave", "para", "la", "expansi贸n", "tisular", "de", "la", "premaxila", ",", "y", "un", "posterior", "aloinjerto", "贸seo", "en", "bloque", "en", "el", "mismo", "lugar", ".", "\n", "Dos", "semanas", "despu茅s", "de", "la", "colocaci贸n", "de", "las", "perlas", "de", "hidrogel", ",", "se", "realiza", "la", "exposici贸n", "y", "retirada", "de", "las", "mismas", ",", "con", "colocaci贸n", "de", "bloques", "de", "aloinjerto", "marca", "Biograft", "庐", ",", "preformados", "transquirurgicamente", "por", "medio", "de", "estereolitograf铆a", ",", "se", "pudo", "realizar", "el", "cierre", "de", "la", "herida", "sin", "tensi贸n", "y", "sin", "la", "necesidad", "de", "realizar", "descargas", "al", "colgajo", ",", "ni", "incisiones", "para", "liberar", "tensi贸n", "del", "periostio", ".", "\n", "Una", "vez", "culminado", "el", "periodo", "de", "oseointegraci贸n", "del", "bloque", "(", "aproximadamente", "6", "meses", ")", ",", "se", "realiza", "la", "colocaci贸n", "de", "los", "implantes", "dentales", ",", "planeados", "inicialmente", "en", "una", "adecuada", "posici贸n", ",", "con", "muy", "buen", "tejido", "贸seo", "y", "blando", "para", "su", "rehabilitaci贸n", ".", "\n", "Responsable", "cl铆nico", ":", "Elias", "Mor谩n", "Pascual", ".", "email", ":", " ", "averquetedigo@hotmail.com", "\n" ]
[ "CORREO_ELECTRONICO", "CALLE", "NOMBRE_PERSONAL_SANITARIO", "NOMBRE_SUJETO_ASISTENCIA", "ID_ASEGURAMIENTO", "ID_TITULACION_PERSONAL_SANITARIO", "FECHAS", "SEXO_SUJETO_ASISTENCIA", "EDAD_SUJETO_ASISTENCIA", "ID_SUJETO_ASISTENCIA", "PAIS", "TERRITORIO" ]
Maritza, Sanchez de Miguel, 8374542, 89 32670766 01, Calle del Aguacate , 44, Madrid, 28040, 20/07/1956, Espa帽a, 54 a帽os, 31/05/2011, Elias Mor谩n Pascual, 28 28 91467, femenino, 54 a帽os, Elias Mor谩n Pascual, averquetedigo@hotmail.com
353_2
Sentence: Datos del paciente. Nombre: Maritza. Apellidos: Sanchez de Miguel. NHC: 8374542. NASS: 89 32670766 01. Domicilio: Calle del Aguacate, 44. Localidad/ Provincia: Madrid. CP: 28040. Datos asistenciales. Fecha de nacimiento: 20/07/1956. Pa铆s de nacimiento: Espa帽a. Edad: 54 a帽os Sexo: M. Fecha de Ingreso: 31/05/2011. M茅dico: Elias Mor谩n Pascual N潞Col: 28 28 91467. Informe cl铆nico del paciente: paciente de sexo femenino, de 54 a帽os de edad, diagnosticada con edentulismo parcial de ambas arcadas y atrofia alveolar severa clase III de Seibert1 en la regi贸n de premaxila ed茅ntula. El plan del tratamiento consiste en la colocaci贸n de 2 perlas de hidrogel esterilizadas en autoclave para la expansi贸n tisular de la premaxila, y un posterior aloinjerto 贸seo en bloque en el mismo lugar. Dos semanas despu茅s de la colocaci贸n de las perlas de hidrogel, se realiza la exposici贸n y retirada de las mismas, con colocaci贸n de bloques de aloinjerto marca Biograft庐, preformados transquirurgicamente por medio de estereolitograf铆a, se pudo realizar el cierre de la herida sin tensi贸n y sin la necesidad de realizar descargas al colgajo, ni incisiones para liberar tensi贸n del periostio. Una vez culminado el periodo de oseointegraci贸n del bloque (aproximadamente 6 meses), se realiza la colocaci贸n de los implantes dentales, planeados inicialmente en una adecuada posici贸n, con muy buen tejido 贸seo y blando para su rehabilitaci贸n. Responsable cl铆nico: Elias Mor谩n Pascual. email: averquetedigo@hotmail.com Instructions: please extract entity words from the input sentence
[ "O", "O", "O", "O", "O", "O", "O", "B-NOMBRE_SUJETO_ASISTENCIA", "O", "O", "O", "O", "B-NOMBRE_SUJETO_ASISTENCIA", "I-NOMBRE_SUJETO_ASISTENCIA", "I-NOMBRE_SUJETO_ASISTENCIA", "O", "O", "O", "O", "B-ID_SUJETO_ASISTENCIA", "O", "O", "O", "O", "B-ID_ASEGURAMIENTO", "I-ID_ASEGURAMIENTO", "I-ID_ASEGURAMIENTO", "O", "O", "O", "O", "B-CALLE", "I-CALLE", "I-CALLE", "I-CALLE", "I-CALLE", "O", "O", "O", "O", "O", "B-TERRITORIO", "O", "O", "O", "O", "B-TERRITORIO", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-FECHAS", "O", "O", "O", "O", "O", "O", "B-PAIS", "O", "O", "O", "O", "B-EDAD_SUJETO_ASISTENCIA", "I-EDAD_SUJETO_ASISTENCIA", "O", "O", "O", "O", "O", "O", "O", "O", "B-FECHAS", "O", "O", "O", "O", "B-NOMBRE_PERSONAL_SANITARIO", "I-NOMBRE_PERSONAL_SANITARIO", "I-NOMBRE_PERSONAL_SANITARIO", "O", "O", "O", "B-ID_TITULACION_PERSONAL_SANITARIO", "I-ID_TITULACION_PERSONAL_SANITARIO", "I-ID_TITULACION_PERSONAL_SANITARIO", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-SEXO_SUJETO_ASISTENCIA", "O", "O", "B-EDAD_SUJETO_ASISTENCIA", "I-EDAD_SUJETO_ASISTENCIA", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-NOMBRE_PERSONAL_SANITARIO", "I-NOMBRE_PERSONAL_SANITARIO", "I-NOMBRE_PERSONAL_SANITARIO", "O", "O", "O", "O", "B-CORREO_ELECTRONICO", "O" ]
Datos del paciente. Nombre: Maritza. Apellidos: Sanchez de Miguel. NHC: 8374542. NASS: 89 32670766 01. Domicilio: Calle del Aguacate, 44. Localidad/ Provincia: Madrid. CP: 28040. Datos asistenciales. Fecha de nacimiento: 20/07/1956. Pa铆s de nacimiento: Espa帽a. Edad: 54 a帽os Sexo: M. Fecha de Ingreso: 31/05/2011. M茅dico: Elias Mor谩n Pascual N潞Col: 28 28 91467. Informe cl铆nico del paciente: paciente de sexo femenino, de 54 a帽os de edad, diagnosticada con edentulismo parcial de ambas arcadas y atrofia alveolar severa clase III de Seibert1 en la regi贸n de premaxila ed茅ntula. El plan del tratamiento consiste en la colocaci贸n de 2 perlas de hidrogel esterilizadas en autoclave para la expansi贸n tisular de la premaxila, y un posterior aloinjerto 贸seo en bloque en el mismo lugar. Dos semanas despu茅s de la colocaci贸n de las perlas de hidrogel, se realiza la exposici贸n y retirada de las mismas, con colocaci贸n de bloques de aloinjerto marca Biograft庐, preformados transquirurgicamente por medio de estereolitograf铆a, se pudo realizar el cierre de la herida sin tensi贸n y sin la necesidad de realizar descargas al colgajo, ni incisiones para liberar tensi贸n del periostio. Una vez culminado el periodo de oseointegraci贸n del bloque (aproximadamente 6 meses), se realiza la colocaci贸n de los implantes dentales, planeados inicialmente en una adecuada posici贸n, con muy buen tejido 贸seo y blando para su rehabilitaci贸n. Responsable cl铆nico: Elias Mor谩n Pascual. email: averquetedigo@hotmail.com
[ "Datos", "del", "paciente", ".", "\n", "Nombre", ":", "Maritza", ".", "\n", "Apellidos", ":", "Sanchez", "de", "Miguel", ".", "\n", "NHC", ":", "8374542", ".", "\n", "NASS", ":", "89", "32670766", "01", ".", "\n", "Domicilio", ":", "Calle", "del", "Aguacate", ",", "44", ".", "\n", "Localidad/", "Provincia", ":", "Madrid", ".", "\n", "CP", ":", "28040", ".", "\n", "Datos", "asistenciales", ".", "\n", "Fecha", "de", "nacimiento", ":", "20/07/1956", ".", "\n", "Pa铆s", "de", "nacimiento", ":", "Espa帽a", ".", "\n", "Edad", ":", "54", "a帽os", "Sexo", ":", "M.", "\n", "Fecha", "de", "Ingreso", ":", "31/05/2011", ".", "\n", "M茅dico", ":", "Elias", "Mor谩n", "Pascual", " ", "N潞Col", ":", "28", "28", "91467", ".", "\n", "Informe", "cl铆nico", "del", "paciente", ":", "paciente", "de", "sexo", "femenino", ",", "de", "54", "a帽os", "de", "edad", ",", "diagnosticada", "con", "edentulismo", "parcial", "de", "ambas", "arcadas", "y", "atrofia", "alveolar", "severa", "clase", "III", "de", "Seibert1", "en", "la", "regi贸n", "de", "premaxila", "ed茅ntula", ".", "\n", "El", "plan", "del", "tratamiento", "consiste", "en", "la", "colocaci贸n", "de", "2", "perlas", "de", "hidrogel", "esterilizadas", "en", "autoclave", "para", "la", "expansi贸n", "tisular", "de", "la", "premaxila", ",", "y", "un", "posterior", "aloinjerto", "贸seo", "en", "bloque", "en", "el", "mismo", "lugar", ".", "\n", "Dos", "semanas", "despu茅s", "de", "la", "colocaci贸n", "de", "las", "perlas", "de", "hidrogel", ",", "se", "realiza", "la", "exposici贸n", "y", "retirada", "de", "las", "mismas", ",", "con", "colocaci贸n", "de", "bloques", "de", "aloinjerto", "marca", "Biograft", "庐", ",", "preformados", "transquirurgicamente", "por", "medio", "de", "estereolitograf铆a", ",", "se", "pudo", "realizar", "el", "cierre", "de", "la", "herida", "sin", "tensi贸n", "y", "sin", "la", "necesidad", "de", "realizar", "descargas", "al", "colgajo", ",", "ni", "incisiones", "para", "liberar", "tensi贸n", "del", "periostio", ".", "\n", "Una", "vez", "culminado", "el", "periodo", "de", "oseointegraci贸n", "del", "bloque", "(", "aproximadamente", "6", "meses", ")", ",", "se", "realiza", "la", "colocaci贸n", "de", "los", "implantes", "dentales", ",", "planeados", "inicialmente", "en", "una", "adecuada", "posici贸n", ",", "con", "muy", "buen", "tejido", "贸seo", "y", "blando", "para", "su", "rehabilitaci贸n", ".", "\n", "Responsable", "cl铆nico", ":", "Elias", "Mor谩n", "Pascual", ".", "email", ":", " ", "averquetedigo@hotmail.com", "\n" ]
[ "CORREO_ELECTRONICO", "CALLE", "NOMBRE_PERSONAL_SANITARIO", "NOMBRE_SUJETO_ASISTENCIA", "ID_ASEGURAMIENTO", "ID_TITULACION_PERSONAL_SANITARIO", "FECHAS", "SEXO_SUJETO_ASISTENCIA", "EDAD_SUJETO_ASISTENCIA", "ID_SUJETO_ASISTENCIA", "PAIS", "TERRITORIO" ]
au(111 ) is a Chemical, ferrocene is a Chemical
27190_0
Sentence: Ideal redox behavior of the high-density self-assembled monolayer of a molecular tripod on a au(111) surface with a terminal ferrocene group. Instructions: please extract entities and their types from the input sentence, all entity types are in options Options: Chemical
[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Chemical", "I-Chemical", "O", "O", "O", "O", "B-Chemical", "O", "O" ]
Ideal redox behavior of the high-density self-assembled monolayer of a molecular tripod on a au(111) surface with a terminal ferrocene group.
[ "Ideal", "redox", "behavior", "of", "the", "high", "-", "density", "self", "-", "assembled", "monolayer", "of", "a", "molecular", "tripod", "on", "a", "au(111", ")", "surface", "with", "a", "terminal", "ferrocene", "group", "." ]
[ "Chemical" ]
au(111 ) is a Chemical, ferrocene is a Chemical
27190_1
Sentence: Ideal redox behavior of the high-density self-assembled monolayer of a molecular tripod on a au(111) surface with a terminal ferrocene group. Instructions: please typing these entity words according to sentence: au(111 ), ferrocene Options: Chemical
[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Chemical", "I-Chemical", "O", "O", "O", "O", "B-Chemical", "O", "O" ]
Ideal redox behavior of the high-density self-assembled monolayer of a molecular tripod on a au(111) surface with a terminal ferrocene group.
[ "Ideal", "redox", "behavior", "of", "the", "high", "-", "density", "self", "-", "assembled", "monolayer", "of", "a", "molecular", "tripod", "on", "a", "au(111", ")", "surface", "with", "a", "terminal", "ferrocene", "group", "." ]
[ "Chemical" ]
au(111 ), ferrocene
27190_2
Sentence: Ideal redox behavior of the high-density self-assembled monolayer of a molecular tripod on a au(111) surface with a terminal ferrocene group. Instructions: please extract entity words from the input sentence
[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Chemical", "I-Chemical", "O", "O", "O", "O", "B-Chemical", "O", "O" ]
Ideal redox behavior of the high-density self-assembled monolayer of a molecular tripod on a au(111) surface with a terminal ferrocene group.
[ "Ideal", "redox", "behavior", "of", "the", "high", "-", "density", "self", "-", "assembled", "monolayer", "of", "a", "molecular", "tripod", "on", "a", "au(111", ")", "surface", "with", "a", "terminal", "ferrocene", "group", "." ]
[ "Chemical" ]